Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Finnish Defense Forces | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
Vitamin D intervention effects on the prevention of acute respiratory tract infections among Young Finnish Men
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| vitamin D3 | Active Comparator | 20 mikrog vitamin D3 daily, 3 months |
|
| Placebo | Placebo Comparator | Placebo |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Vitamin D3 | Dietary Supplement | 20 mikrog vitamin D3 daily |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Days off duty due to acute respiratory tract infections | The number of Days off Duty recommended by Health care personnel will be calculated in order to show the severity and last of the disease. By that it could be estimated how the disease will effect on duty service. | 4 months |
| Measure | Description | Time Frame |
|---|---|---|
| Days off duty due to musculoskeletal disorders | The number of days off Duty because of musculoskeletal disorders will be index for outcome. The index will be compared between plasebo and intervention group | 4 months |
| Aerobic and muscular fitness |
Not provided
Inclusion Criteria;
Exclusion Criteria
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| ilkka laaksi, MDPhD | University of Tampere, Finland | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Finnish Defence Forces | Hämeenlinna | 13210 | Finland |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39301110 | Derived | Laaksi A, Kyrolainen H, Pihlajamaki H, Vaara JP, Luukkaala T, Laaksi I. Effects of Vitamin D Supplementation and Baseline Vitamin D Status on Acute Respiratory Infections and Cathelicidin: A Randomized Controlled Trial. Open Forum Infect Dis. 2024 Aug 27;11(9):ofae482. doi: 10.1093/ofid/ofae482. eCollection 2024 Sep. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014808 | Vitamin D Deficiency |
| D012141 | Respiratory Tract Infections |
| ID | Term |
|---|---|
| D001361 | Avitaminosis |
| D003677 | Deficiency Diseases |
| D044342 | Malnutrition |
| D009748 | Nutrition Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D002762 | Cholecalciferol |
| ID | Term |
|---|---|
| D002782 | Cholestenes |
| D002776 | Cholestanes |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo |
| Dietary Supplement |
Placebo |
|
Used test are Cooper-test for aerobic and Finnish military fitness test for muscular fitness performance. The index will be compared between plasebo and intervention group
| 4 months |
| D009750 |
| Nutritional and Metabolic Diseases |
| D007239 | Infections |
| D012140 | Respiratory Tract Diseases |
| D011083 |
| Polycyclic Compounds |
| D013261 | Sterols |
| D014807 | Vitamin D |
| D012632 | Secosteroids |
| D008563 | Membrane Lipids |
| D008055 | Lipids |